These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 3763941
1. A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction. Cirino M, Lagente V, Lefort J, Vargaftig BB. Prostaglandins; 1986 Jul; 32(1):121-6. PubMed ID: 3763941 [Abstract] [Full Text] [Related]
2. Interference of the PAF-acether antagonist BN 52021 with passive anaphylaxis in the guinea-pig. Lagente V, Touvay C, Randon J, Desquand S, Cirino M, Vilain B, Lefort J, Braquet P, Vargaftig BB. Prostaglandins; 1987 Feb; 33(2):265-74. PubMed ID: 2438723 [Abstract] [Full Text] [Related]
3. Pharmacological control of the in vivo passive anaphylactic shock by the PAF-acether antagonist compound BN 52021. Vilain B, Lagente V, Touvay C, Desquand S, Randon J, Lefort J, Braquet P, Vargaftig BB. Pharmacol Res Commun; 1986 Aug; 18 Suppl():119-26. PubMed ID: 3774840 [Abstract] [Full Text] [Related]
4. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig. Desquand S, Touvay C, Randon J, Lagente V, Vilain B, Maridonneau-Parini I, Etienne A, Lefort J, Braquet P, Vargaftig BB. Eur J Pharmacol; 1986 Aug 07; 127(1-2):83-95. PubMed ID: 3019727 [Abstract] [Full Text] [Related]
5. Involvement of PAF-acether in anaphylactic bronchoconstriction induced in guinea pigs by aerosolized antigen. Lagente V, Cirino M, Desquand S, Lefort J, Vargaftig BB. Int Arch Allergy Appl Immunol; 1988 Aug 07; 85(1):14-9. PubMed ID: 3338855 [Abstract] [Full Text] [Related]
6. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis. Berti F, Omini C, Rossoni G, Braquet P. Pharmacol Res Commun; 1986 Sep 07; 18(9):775-93. PubMed ID: 3099317 [Abstract] [Full Text] [Related]
13. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung. Harczy M, Maclouf J, Pradelles P, Braquet P, Borgeat P, Sirois P. Pharmacol Res Commun; 1986 Aug 07; 18 Suppl():111-7. PubMed ID: 3095849 [Abstract] [Full Text] [Related]
14. Proof of the involvement of platelet activating factor (paf-acether) in pulmonary complex immune systems using a specific paf-acether receptor antagonist: BN 52021. Touvay C, Vilain B, Taylor JE, Etienne A, Braquet P. Prog Lipid Res; 1986 Aug 07; 25(1-4):277-88. PubMed ID: 2827186 [No Abstract] [Full Text] [Related]
15. Inhibition of the vascular actions of IgG aggregates by BN 52021, a highly specific antagonist of paf-acether. Sánchez-Crespo M, Fernández-Gallardo S, Nieto ML, Baranès J, Braquet P. Immunopharmacology; 1985 Oct 07; 10(2):69-75. PubMed ID: 3840779 [Abstract] [Full Text] [Related]
16. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L. Braquet P. Adv Prostaglandin Thromboxane Leukot Res; 1986 Oct 07; 16():179-98. PubMed ID: 2949548 [No Abstract] [Full Text] [Related]
18. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. Baroggi N, Etienne A, Braquet P. Agents Actions Suppl; 1986 Oct 07; 20():87-97. PubMed ID: 3028108 [Abstract] [Full Text] [Related]